Smiley-McDonald et al. find that despite decriminalisation, people who use drugs in Oregon continued to face high levels of policing, incarceration and drug seizures, whilst awareness of decriminalisation remained low.
The HIV Legal Network highlight the deep-rooted colonialism and racism underpinning Canada's drug laws, offering Indigenous people who use drugs crucial knowledge about their legal rights and protections.
Drug Policy Alliance (DPA) explains the decriminalisation model in Oregon, its reversal after a misinformation campaign, and the costs and harms of recriminalisation.
Nelson et al. investigate the many tactics street dealers use to mitigate risks of police harassment, arrest, and violence, and call on the government to focus on systemic rather than law enforcement solutions.
Rouhani et al. explore how US prosecutors use harm reduction principles to shape criminal justice outcomes for people who use drugs, revealing the potential for pro-drug policy reform.
Release, Amnesty International, UNJUST UK, HRI and IDPC shed light on racial disparities in drug policing and associated human rights violations, urging for decriminalisation, the redirection of resources into care systems, and equitable reform.
APCOM and IDPC urge the public, law enforcement, and policymakers in Thailand to help ensure equality and equity for LGBTQ+ people who use drugs, especially in their access to health and social services, and ending stigma and discrimination against them.
US: Re-criminalisation of possession of drugs marks a major U-turn for Oregon, but offers an opportunity for drug policy reformists to address misunderstandings and misinformation about decriminalisation.
EMCDDA and Europol raise concerns on the threats of highly potent synthetic substances and the need to invest in harm reduction approaches, as one of the policy options to address the drug situation in Europe.
